Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: results from a 12-month observational study. (Q44347273)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

title

Buprenorphine-naloxone treatment in opioid dependence and risk of liver enzyme elevation: results from a 12-month observational study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Michael Soyka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Markus Backmund

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

Peggy Schmidt

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

publication date

22 September 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

American Journal on Addictions

19 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

page(s)

563-569

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

19 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Buprenorphine vs Methadone Maintenance Treatment for Concurrent Opioid Dependence and Cocaine Abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of substance use and related disorders. Part 2: Opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Six-year mortality rates of patients in methadone and buprenorphine maintenance therapy: results from a nationally representative cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Retention rate and substance use in methadone and buprenorphine maintenance therapy and predictors of outcome: results from a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Seroprevalence of hepatitis C in a sample of middle class substance abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Age-specific seroprevalence of HIV, hepatitis B virus, and hepatitis C virus infection among injection drug users admitted to drug treatment in 6 US cities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Hepatitis C and substance use in a sample of homeless people in New York City

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Alcohol consumption in heroin users, methadone-substituted and codeine-substituted patients--frequency and correlates of use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Case definition and phenotype standardization in drug-induced liver injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Recognizing drug-induced liver injury: current problems, possible solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Mechanisms for experimental buprenorphine hepatotoxicity: major role of mitochondrial dysfunction versus metabolic activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Hepatitis after intravenous buprenorphine misuse in heroin addicts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Case series on the safe use of buprenorphine/naloxone in individuals with acute hepatitis C infection and abnormal hepatic liver transaminases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Acute liver and renal failure during treatment with buprenorphine at therapeutic dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Safety, effectiveness and tolerance of buprenorphine-naloxone in the treatment of opioid dependence: results from a nationwide non-interventional study in routine care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Buprenorphine/Naloxone and methadone effects on laboratory indices of liver health: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Elevated liver enzyme levels in opioid-dependent patients with hepatitis treated with buprenorphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Hepatitis after intravenous injection of sublingual buprenorphine in acute hepatitis C carriers: report of two cases of disappearance of viral replication after acute hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Acute hepatitis due to buprenorphine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Effect of hepatitis C virus status on liver enzymes in opioid-dependent pregnant women maintained on opioid-agonist medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Effects of buprenorphine and hepatitis C on liver enzymes in adolescents and young adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Hepatic safety and lack of antiretroviral interactions with buprenorphine/naloxone in HIV-infected opioid-dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Neonatal abstinence syndrome after methadone or buprenorphine exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

Different alterations of cytochrome P450 3A4 isoform and its gene expression in livers of patients with chronic liver diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1521-0391.2014.12131.X

10.1111/J.1521-0391.2014.12131.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json

19 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25251050%20AND%20SRC:MED&resulttype=core&format=json